The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dextromethorphan Market Research Report 2024
Synopsis
The d-isomer of the codeine analog of levorphanol. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity.
The global Dextromethorphan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dextromethorphan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dextromethorphan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Dextromethorphan in Cold is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Dextromethorphan include Teva, Sanofi, Johnson & Johnson, Bayer, Bristol-Myers Squibb, GSK, IriSys R&D, TSH Biopharm and Endo International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dextromethorphan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dextromethorphan.
Report Scope
The Dextromethorphan market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dextromethorphan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dextromethorphan companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sanofi
Johnson & Johnson
Bayer
Bristol-Myers Squibb
GSK
IriSys R&D
TSH Biopharm
Endo International
Axsome Therapeutics
Strive Pharmaceuticals
Cellix Bio
Stada Arzneimittel
Yabo Pharmaceutical
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Zhejiang Kangde Pharmaceutical Group
Zhejiang Anbao Pharmaceutical
Jiangsu Zhongtian Pharmaceutical
Segment by Type
Tablets
Syrups
Segment by Application
Cold
Acute Or Chronic Bronchitis
Bronchial Asthma
Sore Throat
Tuberculosis (TB)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dextromethorphan companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The d-isomer of the codeine analog of levorphanol. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity.
The global Dextromethorphan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dextromethorphan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dextromethorphan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Dextromethorphan in Cold is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Dextromethorphan include Teva, Sanofi, Johnson & Johnson, Bayer, Bristol-Myers Squibb, GSK, IriSys R&D, TSH Biopharm and Endo International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dextromethorphan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dextromethorphan.
Report Scope
The Dextromethorphan market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dextromethorphan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dextromethorphan companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sanofi
Johnson & Johnson
Bayer
Bristol-Myers Squibb
GSK
IriSys R&D
TSH Biopharm
Endo International
Axsome Therapeutics
Strive Pharmaceuticals
Cellix Bio
Stada Arzneimittel
Yabo Pharmaceutical
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Zhejiang Kangde Pharmaceutical Group
Zhejiang Anbao Pharmaceutical
Jiangsu Zhongtian Pharmaceutical
Segment by Type
Tablets
Syrups
Segment by Application
Cold
Acute Or Chronic Bronchitis
Bronchial Asthma
Sore Throat
Tuberculosis (TB)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dextromethorphan companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dextromethorphan Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Syrups
1.3 Market by Application
1.3.1 Global Dextromethorphan Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cold
1.3.3 Acute Or Chronic Bronchitis
1.3.4 Bronchial Asthma
1.3.5 Sore Throat
1.3.6 Tuberculosis (TB)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dextromethorphan Market Perspective (2019-2030)
2.2 Dextromethorphan Growth Trends by Region
2.2.1 Global Dextromethorphan Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dextromethorphan Historic Market Size by Region (2019-2024)
2.2.3 Dextromethorphan Forecasted Market Size by Region (2025-2030)
2.3 Dextromethorphan Market Dynamics
2.3.1 Dextromethorphan Industry Trends
2.3.2 Dextromethorphan Market Drivers
2.3.3 Dextromethorphan Market Challenges
2.3.4 Dextromethorphan Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dextromethorphan Players by Revenue
3.1.1 Global Top Dextromethorphan Players by Revenue (2019-2024)
3.1.2 Global Dextromethorphan Revenue Market Share by Players (2019-2024)
3.2 Global Dextromethorphan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dextromethorphan Revenue
3.4 Global Dextromethorphan Market Concentration Ratio
3.4.1 Global Dextromethorphan Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dextromethorphan Revenue in 2023
3.5 Dextromethorphan Key Players Head office and Area Served
3.6 Key Players Dextromethorphan Product Solution and Service
3.7 Date of Enter into Dextromethorphan Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dextromethorphan Breakdown Data by Type
4.1 Global Dextromethorphan Historic Market Size by Type (2019-2024)
4.2 Global Dextromethorphan Forecasted Market Size by Type (2025-2030)
5 Dextromethorphan Breakdown Data by Application
5.1 Global Dextromethorphan Historic Market Size by Application (2019-2024)
5.2 Global Dextromethorphan Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dextromethorphan Market Size (2019-2030)
6.2 North America Dextromethorphan Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dextromethorphan Market Size by Country (2019-2024)
6.4 North America Dextromethorphan Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dextromethorphan Market Size (2019-2030)
7.2 Europe Dextromethorphan Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dextromethorphan Market Size by Country (2019-2024)
7.4 Europe Dextromethorphan Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dextromethorphan Market Size (2019-2030)
8.2 Asia-Pacific Dextromethorphan Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dextromethorphan Market Size by Region (2019-2024)
8.4 Asia-Pacific Dextromethorphan Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dextromethorphan Market Size (2019-2030)
9.2 Latin America Dextromethorphan Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dextromethorphan Market Size by Country (2019-2024)
9.4 Latin America Dextromethorphan Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dextromethorphan Market Size (2019-2030)
10.2 Middle East & Africa Dextromethorphan Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dextromethorphan Market Size by Country (2019-2024)
10.4 Middle East & Africa Dextromethorphan Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Dextromethorphan Introduction
11.1.4 Teva Revenue in Dextromethorphan Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Dextromethorphan Introduction
11.2.4 Sanofi Revenue in Dextromethorphan Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Dextromethorphan Introduction
11.3.4 Johnson & Johnson Revenue in Dextromethorphan Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Dextromethorphan Introduction
11.4.4 Bayer Revenue in Dextromethorphan Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Dextromethorphan Introduction
11.5.4 Bristol-Myers Squibb Revenue in Dextromethorphan Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 GSK
11.6.1 GSK Company Detail
11.6.2 GSK Business Overview
11.6.3 GSK Dextromethorphan Introduction
11.6.4 GSK Revenue in Dextromethorphan Business (2019-2024)
11.6.5 GSK Recent Development
11.7 IriSys R&D
11.7.1 IriSys R&D Company Detail
11.7.2 IriSys R&D Business Overview
11.7.3 IriSys R&D Dextromethorphan Introduction
11.7.4 IriSys R&D Revenue in Dextromethorphan Business (2019-2024)
11.7.5 IriSys R&D Recent Development
11.8 TSH Biopharm
11.8.1 TSH Biopharm Company Detail
11.8.2 TSH Biopharm Business Overview
11.8.3 TSH Biopharm Dextromethorphan Introduction
11.8.4 TSH Biopharm Revenue in Dextromethorphan Business (2019-2024)
11.8.5 TSH Biopharm Recent Development
11.9 Endo International
11.9.1 Endo International Company Detail
11.9.2 Endo International Business Overview
11.9.3 Endo International Dextromethorphan Introduction
11.9.4 Endo International Revenue in Dextromethorphan Business (2019-2024)
11.9.5 Endo International Recent Development
11.10 Axsome Therapeutics
11.10.1 Axsome Therapeutics Company Detail
11.10.2 Axsome Therapeutics Business Overview
11.10.3 Axsome Therapeutics Dextromethorphan Introduction
11.10.4 Axsome Therapeutics Revenue in Dextromethorphan Business (2019-2024)
11.10.5 Axsome Therapeutics Recent Development
11.11 Strive Pharmaceuticals
11.11.1 Strive Pharmaceuticals Company Detail
11.11.2 Strive Pharmaceuticals Business Overview
11.11.3 Strive Pharmaceuticals Dextromethorphan Introduction
11.11.4 Strive Pharmaceuticals Revenue in Dextromethorphan Business (2019-2024)
11.11.5 Strive Pharmaceuticals Recent Development
11.12 Cellix Bio
11.12.1 Cellix Bio Company Detail
11.12.2 Cellix Bio Business Overview
11.12.3 Cellix Bio Dextromethorphan Introduction
11.12.4 Cellix Bio Revenue in Dextromethorphan Business (2019-2024)
11.12.5 Cellix Bio Recent Development
11.13 Stada Arzneimittel
11.13.1 Stada Arzneimittel Company Detail
11.13.2 Stada Arzneimittel Business Overview
11.13.3 Stada Arzneimittel Dextromethorphan Introduction
11.13.4 Stada Arzneimittel Revenue in Dextromethorphan Business (2019-2024)
11.13.5 Stada Arzneimittel Recent Development
11.14 Yabo Pharmaceutical
11.14.1 Yabo Pharmaceutical Company Detail
11.14.2 Yabo Pharmaceutical Business Overview
11.14.3 Yabo Pharmaceutical Dextromethorphan Introduction
11.14.4 Yabo Pharmaceutical Revenue in Dextromethorphan Business (2019-2024)
11.14.5 Yabo Pharmaceutical Recent Development
11.15 Zhuhai Tianda Pharma
11.15.1 Zhuhai Tianda Pharma Company Detail
11.15.2 Zhuhai Tianda Pharma Business Overview
11.15.3 Zhuhai Tianda Pharma Dextromethorphan Introduction
11.15.4 Zhuhai Tianda Pharma Revenue in Dextromethorphan Business (2019-2024)
11.15.5 Zhuhai Tianda Pharma Recent Development
11.16 Sichuan Shenghe Pharmaceutical
11.16.1 Sichuan Shenghe Pharmaceutical Company Detail
11.16.2 Sichuan Shenghe Pharmaceutical Business Overview
11.16.3 Sichuan Shenghe Pharmaceutical Dextromethorphan Introduction
11.16.4 Sichuan Shenghe Pharmaceutical Revenue in Dextromethorphan Business (2019-2024)
11.16.5 Sichuan Shenghe Pharmaceutical Recent Development
11.17 Zhejiang Kangde Pharmaceutical Group
11.17.1 Zhejiang Kangde Pharmaceutical Group Company Detail
11.17.2 Zhejiang Kangde Pharmaceutical Group Business Overview
11.17.3 Zhejiang Kangde Pharmaceutical Group Dextromethorphan Introduction
11.17.4 Zhejiang Kangde Pharmaceutical Group Revenue in Dextromethorphan Business (2019-2024)
11.17.5 Zhejiang Kangde Pharmaceutical Group Recent Development
11.18 Zhejiang Anbao Pharmaceutical
11.18.1 Zhejiang Anbao Pharmaceutical Company Detail
11.18.2 Zhejiang Anbao Pharmaceutical Business Overview
11.18.3 Zhejiang Anbao Pharmaceutical Dextromethorphan Introduction
11.18.4 Zhejiang Anbao Pharmaceutical Revenue in Dextromethorphan Business (2019-2024)
11.18.5 Zhejiang Anbao Pharmaceutical Recent Development
11.19 Jiangsu Zhongtian Pharmaceutical
11.19.1 Jiangsu Zhongtian Pharmaceutical Company Detail
11.19.2 Jiangsu Zhongtian Pharmaceutical Business Overview
11.19.3 Jiangsu Zhongtian Pharmaceutical Dextromethorphan Introduction
11.19.4 Jiangsu Zhongtian Pharmaceutical Revenue in Dextromethorphan Business (2019-2024)
11.19.5 Jiangsu Zhongtian Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Dextromethorphan Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablets
Table 3. Key Players of Syrups
Table 4. Global Dextromethorphan Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Dextromethorphan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Dextromethorphan Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Dextromethorphan Market Share by Region (2019-2024)
Table 8. Global Dextromethorphan Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Dextromethorphan Market Share by Region (2025-2030)
Table 10. Dextromethorphan Market Trends
Table 11. Dextromethorphan Market Drivers
Table 12. Dextromethorphan Market Challenges
Table 13. Dextromethorphan Market Restraints
Table 14. Global Dextromethorphan Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Dextromethorphan Market Share by Players (2019-2024)
Table 16. Global Top Dextromethorphan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dextromethorphan as of 2023)
Table 17. Ranking of Global Top Dextromethorphan Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Dextromethorphan Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dextromethorphan Product Solution and Service
Table 21. Date of Enter into Dextromethorphan Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dextromethorphan Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Dextromethorphan Revenue Market Share by Type (2019-2024)
Table 25. Global Dextromethorphan Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Dextromethorphan Revenue Market Share by Type (2025-2030)
Table 27. Global Dextromethorphan Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Dextromethorphan Revenue Market Share by Application (2019-2024)
Table 29. Global Dextromethorphan Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Dextromethorphan Revenue Market Share by Application (2025-2030)
Table 31. North America Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Dextromethorphan Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Dextromethorphan Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Dextromethorphan Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Dextromethorphan Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Dextromethorphan Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Dextromethorphan Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Dextromethorphan Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Dextromethorphan Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Dextromethorphan Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Dextromethorphan Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Dextromethorphan Market Size by Country (2025-2030) & (US$ Million)
Table 46. Teva Company Detail
Table 47. Teva Business Overview
Table 48. Teva Dextromethorphan Product
Table 49. Teva Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 50. Teva Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Dextromethorphan Product
Table 54. Sanofi Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Dextromethorphan Product
Table 59. Johnson & Johnson Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Bayer Company Detail
Table 62. Bayer Business Overview
Table 63. Bayer Dextromethorphan Product
Table 64. Bayer Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Bristol-Myers Squibb Company Detail
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Dextromethorphan Product
Table 69. Bristol-Myers Squibb Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. GSK Company Detail
Table 72. GSK Business Overview
Table 73. GSK Dextromethorphan Product
Table 74. GSK Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 75. GSK Recent Development
Table 76. IriSys R&D Company Detail
Table 77. IriSys R&D Business Overview
Table 78. IriSys R&D Dextromethorphan Product
Table 79. IriSys R&D Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 80. IriSys R&D Recent Development
Table 81. TSH Biopharm Company Detail
Table 82. TSH Biopharm Business Overview
Table 83. TSH Biopharm Dextromethorphan Product
Table 84. TSH Biopharm Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 85. TSH Biopharm Recent Development
Table 86. Endo International Company Detail
Table 87. Endo International Business Overview
Table 88. Endo International Dextromethorphan Product
Table 89. Endo International Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 90. Endo International Recent Development
Table 91. Axsome Therapeutics Company Detail
Table 92. Axsome Therapeutics Business Overview
Table 93. Axsome Therapeutics Dextromethorphan Product
Table 94. Axsome Therapeutics Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 95. Axsome Therapeutics Recent Development
Table 96. Strive Pharmaceuticals Company Detail
Table 97. Strive Pharmaceuticals Business Overview
Table 98. Strive Pharmaceuticals Dextromethorphan Product
Table 99. Strive Pharmaceuticals Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 100. Strive Pharmaceuticals Recent Development
Table 101. Cellix Bio Company Detail
Table 102. Cellix Bio Business Overview
Table 103. Cellix Bio Dextromethorphan Product
Table 104. Cellix Bio Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 105. Cellix Bio Recent Development
Table 106. Stada Arzneimittel Company Detail
Table 107. Stada Arzneimittel Business Overview
Table 108. Stada Arzneimittel Dextromethorphan Product
Table 109. Stada Arzneimittel Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 110. Stada Arzneimittel Recent Development
Table 111. Yabo Pharmaceutical Company Detail
Table 112. Yabo Pharmaceutical Business Overview
Table 113. Yabo Pharmaceutical Dextromethorphan Product
Table 114. Yabo Pharmaceutical Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 115. Yabo Pharmaceutical Recent Development
Table 116. Zhuhai Tianda Pharma Company Detail
Table 117. Zhuhai Tianda Pharma Business Overview
Table 118. Zhuhai Tianda Pharma Dextromethorphan Product
Table 119. Zhuhai Tianda Pharma Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 120. Zhuhai Tianda Pharma Recent Development
Table 121. Sichuan Shenghe Pharmaceutical Company Detail
Table 122. Sichuan Shenghe Pharmaceutical Business Overview
Table 123. Sichuan Shenghe Pharmaceutical Dextromethorphan Product
Table 124. Sichuan Shenghe Pharmaceutical Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 125. Sichuan Shenghe Pharmaceutical Recent Development
Table 126. Zhejiang Kangde Pharmaceutical Group Company Detail
Table 127. Zhejiang Kangde Pharmaceutical Group Business Overview
Table 128. Zhejiang Kangde Pharmaceutical Group Dextromethorphan Product
Table 129. Zhejiang Kangde Pharmaceutical Group Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 130. Zhejiang Kangde Pharmaceutical Group Recent Development
Table 131. Zhejiang Anbao Pharmaceutical Company Detail
Table 132. Zhejiang Anbao Pharmaceutical Business Overview
Table 133. Zhejiang Anbao Pharmaceutical Dextromethorphan Product
Table 134. Zhejiang Anbao Pharmaceutical Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 135. Zhejiang Anbao Pharmaceutical Recent Development
Table 136. Jiangsu Zhongtian Pharmaceutical Company Detail
Table 137. Jiangsu Zhongtian Pharmaceutical Business Overview
Table 138. Jiangsu Zhongtian Pharmaceutical Dextromethorphan Product
Table 139. Jiangsu Zhongtian Pharmaceutical Revenue in Dextromethorphan Business (2019-2024) & (US$ Million)
Table 140. Jiangsu Zhongtian Pharmaceutical Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dextromethorphan Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Dextromethorphan Market Share by Type: 2023 VS 2030
Figure 3. Tablets Features
Figure 4. Syrups Features
Figure 5. Global Dextromethorphan Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Dextromethorphan Market Share by Application: 2023 VS 2030
Figure 7. Cold Case Studies
Figure 8. Acute Or Chronic Bronchitis Case Studies
Figure 9. Bronchial Asthma Case Studies
Figure 10. Sore Throat Case Studies
Figure 11. Tuberculosis (TB) Case Studies
Figure 12. Dextromethorphan Report Years Considered
Figure 13. Global Dextromethorphan Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Dextromethorphan Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Dextromethorphan Market Share by Region: 2023 VS 2030
Figure 16. Global Dextromethorphan Market Share by Players in 2023
Figure 17. Global Top Dextromethorphan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dextromethorphan as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Dextromethorphan Revenue in 2023
Figure 19. North America Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Dextromethorphan Market Share by Country (2019-2030)
Figure 21. United States Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Dextromethorphan Market Share by Country (2019-2030)
Figure 25. Germany Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Dextromethorphan Market Share by Region (2019-2030)
Figure 33. China Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Dextromethorphan Market Share by Country (2019-2030)
Figure 41. Mexico Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Dextromethorphan Market Share by Country (2019-2030)
Figure 45. Turkey Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Dextromethorphan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Teva Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 48. Sanofi Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 49. Johnson & Johnson Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 50. Bayer Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 52. GSK Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 53. IriSys R&D Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 54. TSH Biopharm Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 55. Endo International Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 56. Axsome Therapeutics Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 57. Strive Pharmaceuticals Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 58. Cellix Bio Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 59. Stada Arzneimittel Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 60. Yabo Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 61. Zhuhai Tianda Pharma Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 62. Sichuan Shenghe Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 63. Zhejiang Kangde Pharmaceutical Group Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 64. Zhejiang Anbao Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 65. Jiangsu Zhongtian Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
